<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01603953</url>
  </required_header>
  <id_info>
    <org_study_id>Gas-549-09-12-1</org_study_id>
    <nct_id>NCT01603953</nct_id>
  </id_info>
  <brief_title>Bioelectrical Impedance Vector Analysis in Cirrhotic Patients</brief_title>
  <acronym>BIVA</acronym>
  <official_title>Malnutrition Assessed Through Bioelectrical Impedance Vector Analysis is Related to Poor Prognosis in Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Protein-energy malnutrition and muscle wasting are a common finding among patients with liver
      cirrhosis. Its prevalence may range from 50-90% depending on the methods used for nutritional
      assessment. Even stable cirrhotic patients referred as Child A have muscle depletion and the
      majority of patients classified as Child C have significant depletion. Malnutrition has been
      shown to be related to several complications of cirrhosis

      Despite the importance of nutritional status in patient's outcome, there is no gold standard
      for nutritional assessment. Traditional techniques used in healthy subjects to assess
      nutritional status cannot be used in cirrhotic patients due especially to ascites and
      peripheral edema, and altered rates of biochemical markers due to liver failure.

      Bioelectrical impedance vector analysis has emerged as a useful method to assess body
      composition and nutritional status especially in patients at the extremes of body weight
      (fluid overload, excess of adipose tissue, etc.).

      The aim of this study is to evaluate whether malnutrition assessed by bioelectrical impedance
      vector analysis is related to the development of hepatic encephalopathy
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic encephalopathy</measure>
    <time_frame>6, 12, 24, 36 and 48 months</time_frame>
    <description>Assessed by west Haven criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ascites</measure>
    <time_frame>6, 12, 24, 36 and 48 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">250</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hepatic Encephalopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The participants will be recruited from the Gastroenterology Department of a tertiary care
        setting.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnose of cirrhosis.

          -  Ambulatory patients

        Exclusion Criteria:

          -  Personal history of surgery in the last four weeks

          -  Thyroid disorders without replacement therapy

          -  Pregnancy

          -  Active alcoholism with alcohol ingest in the previous 6 months.

          -  Acute or chronic renal failure

          -  Hepatic or renal transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Torre Delgadillo, M.D. M.Sc</last_name>
    <role>Study Chair</role>
    <affiliation>INCMNSZ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Astrid Ruiz-Margáin, B.Sci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</name>
      <address>
        <city>Mexico City</city>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2012</study_first_submitted>
  <study_first_submitted_qc>May 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2012</study_first_posted>
  <last_update_submitted>November 17, 2014</last_update_submitted>
  <last_update_submitted_qc>November 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>M.D. M.Sc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hepatic Encephalopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

